Aura Minerals reports Q4 results; initiates FY23 and maintains long-term guidance [ad_2] Source link Post navigation Analysis-Investors consider battle plans amid risk of China-Taiwan conflict By Reuters Acadia Pharmaceuticals PT Lowered to $22 at JMP Securities